Genertec Universal Medical subsidiary to issue RMB200m notes

Genertec Universal International Financial Leasing (Tianjin), a subsidiary of Genertec Universal Medical Group, has registered the issuance of domestic medium-term notes with an aggregate principal amount of up to RMB1bn in China. The subsidiary will launch the first tranche of these notes for 2025, known as the "T1 Notes," with a principal amount of up to RMB0.2bn.

The T1 Notes will have a two-year term with a fixed interest rate determined through book-building. The proceeds are intended to repay the issuer's maturing debts. China Minsheng Banking and Evergrowing Bank are the joint lead underwriters.

The notes will be issued to domestic institutional investors in China and are expected to trade on the inter-bank bond market from November 12, 2025. The issuer holds an AAA credit rating.